| Glycosylation and Glycoproteins Research | Lifetime | 55 | US 31 | 99.64 |
| Cancer Cells and Metastasis | Lifetime | 37 | US 29 | 99.68 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 93 | US 54 | 99.67 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 191 | US 125 | 99.60 |
| Galectins and Cancer Biology | Lifetime | 61 | US 27 | 98.89 |
| Cancer Research and Treatments | Lifetime | 249 | US 154 | 98.39 |
| GDF15 and Related Biomarkers | Lifetime | 28 | US 12 | 97.69 |
| Epigenetics and DNA Methylation | Lifetime | 630 | US 327 | 98.53 |
| Hedgehog Signaling Pathway Studies | Lifetime | 135 | US 78 | 97.69 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 914 | US 424 | 97.89 |
| HER2/EGFR in Cancer Research | Lifetime | 416 | US 196 | 98.25 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 653 | US 263 | 96.94 |
| Phagocytosis and Immune Regulation | Lifetime | 299 | US 121 | 95.25 |
| Macrophage Migration Inhibitory Factor | Lifetime | 168 | US 83 | 94.00 |
| FOXO transcription factor regulation | Lifetime | 136 | US 78 | 93.27 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 77 | US 24 | 99.02 |
| Cancer Cells and Metastasis | 2021-2025 | 59 | US 14 | 97.26 |
| Epigenetics and DNA Methylation | 2021-2025 | 247 | US 84 | 95.64 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 163 | US 45 | 95.44 |
| Glycosylation and Glycoproteins Research | 2021-2025 | 85 | US 29 | 95.87 |
| Cancer Research and Treatments | 2021-2025 | 173 | US 46 | 92.03 |
| Phagocytosis and Immune Regulation | 2021-2025 | 115 | US 40 | 88.69 |
| Chemokine receptors and signaling | 2021-2025 | 70 | US 13 | 86.08 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 48 | US 11 | 82.53 |
| GDF15 and Related Biomarkers | 2021-2025 | 111 | US 30 | 81.80 |
| Galectins and Cancer Biology | 2021-2025 | 272 | US 54 | 81.86 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 561 | US 163 | 81.87 |
| Cancer-related gene regulation | 2021-2025 | 775 | US 125 | 79.60 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 286 | US 87 | 70.74 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 504 | US 119 | 66.22 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 681 | US 141 | 61.74 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 511 | US 127 | 58.02 |
| FOXO transcription factor regulation | 2021-2025 | 450 | US 119 | 33.48 |
